Endocrinology · Short-acting insulin
Insulin (Actrapid / Aspart)
Dose
DKA: 0.1 U/kg/h IV. HyperK: 10 U in 50 mL 50% dextrose IV over 15 min. SC sliding scale per local.
Indications
- • DKA
- • HHS
- • Hyperkalaemia
- • Hyperglycaemia
Dilution & preparation
50 U in 50 mL NS (1 U/mL) IV infusion
Use
Monitoring
Side effects
- • Hypoglycaemia
- • Hypokalaemia
- • Weight gain (chronic)
Related in WardRound
Insulin Infusion (Regular) dilution
Dilution · 50 U / 50 mL NS → 1 U/mL
Diabetic Ketoacidosis (DKA)
Protocol · Insulin + fluids + K⁺
Hyperosmolar Hyperglycaemic State
Protocol · Slow fluid resuscitation
Acute Kidney Injury
Protocol · KDIGO staging
Hyperkalaemia
Protocol · K⁺ > 5.5 mmol/L
Hypoglycaemia
Protocol · BSL < 4 mmol/L
HHS Complications
Protocol · Slow correction to prevent oedema
Type 2 Diabetes Mellitus
Topic · Endocrinology
Hyperkalaemia
Topic · Emergency Medicine
Diabetic Ketoacidosis
Topic · Emergency Medicine
β-Blocker Overdose
Topic · Toxicology
Calcium Channel Blocker Overdose
Topic · Toxicology
Gestational Diabetes Mellitus
Topic · Obs/Gynae
Always confirm dose against your local formulary / BNF before prescribing.
